查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881589

泌尿系結石治療器材市場－全球產業規模、佔有率、趨勢、機會和預測，依治療類型、最終用途、地區和競爭格局分類，2020-2030年預測

Urolithiasis Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By End Use, By Region, and By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球泌尿系結石治療器材市場規模為20.1億美元，預計2030年將以4.97%的複合年成長率成長至26.9億美元。泌尿系結石治療器械涵蓋一系列用於診斷、治療和預防腎結石及其他泌尿系統結石的醫療器械。該市場成長強勁，主要受全球泌尿系結石盛行率上升以及患者對微創手術日益成長的需求所驅動，微創手術能夠改善患者預後並縮短恢復時間。醫療技術的進步，包括先進的雷射碎石機和軟性輸尿管鏡，透過提供更有效的結石碎裂和取出方案，進一步推動了市場擴張。

市場概覽
預測期 2026-2030
2024年市場規模 20.1億美元
2030年市場規模 26.9億美元
2025-2030年複合年成長率 4.97%
成長最快的細分市場 體內碎石術
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球泌尿道結石治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依治療類型（體外震波碎石術 (ESWL)、體內碎石術、經皮腎鏡取石術、其他）
    • 依最終用途（醫院和診所、門診手術中心、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美泌尿道結石治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲泌尿結石治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區泌尿科結石治療器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲泌尿結石治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲泌尿道結石治療器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球泌尿道結石治療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Allengers Medical Systems Ltd
  • Boston Scientific Corp
  • Cook Medical Inc
  • CONMED Corp
  • DiREX Group
  • Dornier MedTech GmbH
  • HealthTronics Inc
  • Karl Storz SE & Co KG
  • Lumenis Inc
  • Siemens Healthcare Ltd

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21201

The Global Urolithiasis Management Devices Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 4.97% to reach USD 2.69 Billion by 2030. Urolithiasis management devices encompass a range of medical instruments essential for the diagnosis, treatment, and prevention of kidney stones and other urinary tract calculi. This market experiences robust growth primarily driven by the increasing global prevalence of urolithiasis, coupled with a growing preference for minimally invasive surgical procedures that offer enhanced patient outcomes and reduced recovery times. Advancements in medical technologies, including sophisticated laser lithotripters and flexible ureteroscopes, further stimulate market expansion by providing more effective stone fragmentation and removal solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.01 Billion
Market Size 2030USD 2.69 Billion
CAGR 2025-20304.97%
Fastest Growing SegmentIntracorporeal Lithotripsy
Largest MarketNorth America

Key Market Drivers

The rising global burden of urolithiasis primarily drives the Global Urolithiasis Management Devices Market, with increasing prevalence expanding the patient population needing intervention. Shifting lifestyles, dietary habits, and metabolic disorders contribute to this growing caseload. According to "The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021" via ResearchGate, in November 2024, there were 106 million incident cases of urolithiasis in 2021. This incidence ensures consistent demand for detection, treatment, and prevention instruments, stimulating market growth. The broader urology devices market reflects robust strategic investment; HealthLeaders Media reported in January 2024 that Boston Scientific acquired Axonics for $3.7 billion, underscoring significant financial commitments.

Key Market Challenges

The high cost associated with advanced urolithiasis management devices and surgical interventions presents a significant impediment to market growth. This financial burden directly restricts widespread adoption, particularly in developing regions where healthcare budgets are limited and patient out-of-pocket expenses are substantial. The investment required for advanced equipment, such as laser lithotripters and flexible ureteroscopes, can be prohibitive for many healthcare facilities. This limitation curtails the market penetration of innovative solutions, thereby reducing potential sales and usage in areas with a high prevalence of urinary tract calculi.

Key Market Trends

The increasing shift of urological procedures to Ambulatory Surgical Centers (ASCs) is a significant trend impacting the global urolithiasis management devices market. This trend is driven by the advantages ASCs offer, such as cost-effectiveness for patients and healthcare systems, shorter waiting times, and a more streamlined patient experience compared to traditional hospital settings. As procedures become less invasive and technological advancements facilitate outpatient care, more complex urological interventions, including certain stone removal procedures, are being safely performed in ASCs. According to a March 2025 report from MedPAC, the volume of ASC surgical procedures per fee-for-service Medicare beneficiary rose by 5.7 percent in 2023. This expansion directly influences device manufacturers to adapt their sales and distribution strategies to cater to the unique procurement and inventory management needs of ASCs, fostering demand for devices optimized for outpatient use.

Key Market Players

  • Allengers Medical Systems Ltd
  • Boston Scientific Corp
  • Cook Medical Inc
  • CONMED Corp
  • DiREX Group
  • Dornier MedTech GmbH
  • HealthTronics Inc
  • Karl Storz SE & Co KG
  • Lumenis Inc
  • Siemens Healthcare Ltd

Report Scope:

In this report, the Global Urolithiasis Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urolithiasis Management Devices Market, By Treatment Type:

  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Intracorporeal Lithotripsy
  • Percutaneous Nephrolithotomy
  • Others

Urolithiasis Management Devices Market, By End Use:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Urolithiasis Management Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Urolithiasis Management Devices Market.

Available Customizations:

Global Urolithiasis Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urolithiasis Management Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others)
    • 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Urolithiasis Management Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment Type
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Urolithiasis Management Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Urolithiasis Management Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Urolithiasis Management Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment Type
        • 6.3.3.2.2. By End Use

7. Europe Urolithiasis Management Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment Type
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Urolithiasis Management Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Urolithiasis Management Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Urolithiasis Management Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Urolithiasis Management Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Urolithiasis Management Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment Type
        • 7.3.5.2.2. By End Use

8. Asia Pacific Urolithiasis Management Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment Type
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Urolithiasis Management Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Urolithiasis Management Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Urolithiasis Management Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Urolithiasis Management Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Urolithiasis Management Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment Type
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Urolithiasis Management Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment Type
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Urolithiasis Management Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Urolithiasis Management Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Urolithiasis Management Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment Type
        • 9.3.3.2.2. By End Use

10. South America Urolithiasis Management Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment Type
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Urolithiasis Management Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Urolithiasis Management Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Urolithiasis Management Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment Type
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Urolithiasis Management Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Allengers Medical Systems Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific Corp
  • 15.3. Cook Medical Inc
  • 15.4. CONMED Corp
  • 15.5. DiREX Group
  • 15.6. Dornier MedTech GmbH
  • 15.7. HealthTronics Inc
  • 15.8. Karl Storz SE & Co KG
  • 15.9. Lumenis Inc
  • 15.10. Siemens Healthcare Ltd

16. Strategic Recommendations

17. About Us & Disclaimer